Jump to content

Zomebazam

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Monkbot (talk | contribs) at 14:56, 3 January 2021 (Task 18 (cosmetic): eval 1 template: hyphenate params (1×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Zomebazam
Identifiers
  • 1,3,8-trimethyl-4-phenylpyrazolo[3,4-b][1,4]diazepine-5,7-dione
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H16N4O2
Molar mass284.319 g·mol−1
3D model (JSmol)
  • O=C1N(c2c(N(C(=O)C1)C)n(nc2C)C)c3ccccc3
  • InChI=1S/C15H16N4O2/c1-10-14-15(18(3)16-10)17(2)12(20)9-13(21)19(14)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3 ☒N
  • Key:BFWACMHTIVUWJS-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Zomebazam[1] produced by Hoechst is a pyrazolodiazepinone derivative drug with anxiolytic properties. It is structurally related to razobazam and zometapine.[2]

See also

References

  1. ^ US Patent 3,558,605 '4-Aryl-5,6,7,8-tetrahydropyrazolo(3,4-B)-(1,5)diazepine-1H,4H-5,7-diones and medicaments containing same'
  2. ^ "zomebazam". psychotropics.dk. 2003. Retrieved 7 December 2009.
Stub icon

This sedative-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Zomebazam&oldid=998044468"